Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengqiang Li

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Translational Lung Cancer Research|September 11, 2023
Augmented reality navigation-guided intraoperative pulmonary nodule localization: a pilot studyChengqiang Li, Anqi Ji, Zheng Jian, et al.
Thoracic Cancer|April 24, 2023
Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohortWei-Xiang Qi, Xiaoyan Wang, Chengqiang Li, et al.
Frontiers in Oncology|August 13, 2019
Dosimetric and Radiobiological Comparison of External Beam Radiotherapy Using Simultaneous Integrated Boost Technique for Esophageal Cancer in Different LocationLu Wang, Chengqiang Li, Xue Meng, et al.
Medicine|May 2, 2015
Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot studyJing Liu, Chengqiang Li, Man Hu, et al.
International Journal of Clinical Oncology|June 11, 2026
Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradioimmunotherapy for locally advanced esophageal squamous cell carcinomaLiqiang Shi, Yingyi Li, Chengqiang Li, et al.
Briefings in Bioinformatics|December 18, 2024
A novel computational model ITHCS for enhanced prognostic risk stratification in ESCC by correcting for intratumor heterogeneityTong Lu, Wei Guo, Wei Guo, et al.
Medical Physics|June 26, 2021
Technical Note: End-to-end verification of an MR-Linac using a dynamic motion phantomXuechun Liu, Chengqiang Li, Jian Zhu, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 4, 2026
Clinical-radiomics signature predicts pathologic complete response after neoadjuvant therapy in esophageal squamous cell carcinomaLiqiang Shi, Xipeng Wang, Xueyu Chen, et al.
Journal of Thoracic Disease|August 18, 2020
The classification and treatment strategies of post-esophagectomy airway-gastric fistulaChangchun Wang, Chengqiang Li, Xun Yang, et al.
Precision Radiation Oncology|October 30, 2025
Clinical advances and challenges in dose constraints for organs at risk in proton therapy: A systematic review of the last decade's literatureJinghao Duan, Cheng Tao, Shizhang Wu, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Translational Lung Cancer Research|September 11, 2023
Augmented reality navigation-guided intraoperative pulmonary nodule localization: a pilot studyChengqiang Li, Anqi Ji, Zheng Jian, et al.
Thoracic Cancer|April 24, 2023
Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohortWei-Xiang Qi, Xiaoyan Wang, Chengqiang Li, et al.
Frontiers in Oncology|August 13, 2019
Dosimetric and Radiobiological Comparison of External Beam Radiotherapy Using Simultaneous Integrated Boost Technique for Esophageal Cancer in Different LocationLu Wang, Chengqiang Li, Xue Meng, et al.
Medicine|May 2, 2015
Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot studyJing Liu, Chengqiang Li, Man Hu, et al.
International Journal of Clinical Oncology|June 11, 2026
Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradioimmunotherapy for locally advanced esophageal squamous cell carcinomaLiqiang Shi, Yingyi Li, Chengqiang Li, et al.
Briefings in Bioinformatics|December 18, 2024
A novel computational model ITHCS for enhanced prognostic risk stratification in ESCC by correcting for intratumor heterogeneityTong Lu, Wei Guo, Wei Guo, et al.
Medical Physics|June 26, 2021
Technical Note: End-to-end verification of an MR-Linac using a dynamic motion phantomXuechun Liu, Chengqiang Li, Jian Zhu, et al.
Interdisciplinary Cardiovascular and Thoracic Surgery|February 4, 2026
Clinical-radiomics signature predicts pathologic complete response after neoadjuvant therapy in esophageal squamous cell carcinomaLiqiang Shi, Xipeng Wang, Xueyu Chen, et al.
Journal of Thoracic Disease|August 18, 2020
The classification and treatment strategies of post-esophagectomy airway-gastric fistulaChangchun Wang, Chengqiang Li, Xun Yang, et al.
Precision Radiation Oncology|October 30, 2025
Clinical advances and challenges in dose constraints for organs at risk in proton therapy: A systematic review of the last decade's literatureJinghao Duan, Cheng Tao, Shizhang Wu, et al.
Pageof 8